Clinical Trial

Single and Multiple Ascending Dosing Administration of MF-300 in Healthy Participants

Name: Single and Multiple Ascending Dosing Administration of MF-300 in Healthy Participants — clinical trial record (NCT07613684)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The study will consist of 2 parts, Study Parts 1 (1a: single ascending dose \[SAD\] Phase; and 1b: Food Effect Phase) and Part 2 (multiple ascending dose \[MAD\] Phase). The SAD and MAD phases will evaluate separately non-elderly (≥ 18 to ≤ 65 years of age) and elderly (\> 65 to ≤75 years of age) healthy adult subjects.

Trial Details

NCT Number	NCT07613684
Lead Sponsor	Epirium Bio Inc.
Conditions	Healthy Volunteers
Enrollment	100 participants
Start Date	2024-12-20
Primary Completion	2025-10-09 (estimated)
Study Completion	2025-10-09 (estimated)
Updated on ClinicalTrials.gov	2026-05-29